Core Laboratories (NYSE:CLB) Shares Cross Above 200-Day Moving Average - Here's What Happened

Key Points

• Technical move: Core Laboratories' shares crossed above the 200‑day moving average ($16.35), trading as high as $16.95 and last at $16.9290 on volume of about 391,757 shares, up roughly 2.8%.
• Analysts & fundamentals: The consensus rating is a "Hold" (four analysts) with a $12.50 price target; the company posted a slight EPS beat ($0.21 vs. $0.20), set Q1 2026 guidance of $0.110–0.150, and has a market cap near $780M with a 0.2% dividend yield.

Core Laboratories Inc. (NYSE:CLB - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $16.35 and traded as high as $16.95. Core Laboratories shares last traded at $16.9290, with a volume of 391,757 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Core Laboratories in a research report on Friday, March 27th. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $12.50.

Core Laboratories Trading Up 2.8%

The firm has a market capitalization of $779.58 million, a PE ratio of 25.27, a price-to-earnings-growth ratio of 2.58 and a beta of 1.15. The stock's 50-day moving average price is $17.04 and its 200 day moving average price is $16.35. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.51.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. The business had revenue of $138.26 million for the quarter, compared to analyst estimates of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company posted $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, sell-side analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories's dividend payout ratio (DPR) is presently 5.97%.

Hedge Funds Weigh In On Core Laboratories

Several institutional investors have recently bought and sold shares of the business. Disciplined Growth Investors Inc. MN increased its holdings in Core Laboratories by 9.7% during the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company's stock valued at $73,787,000 after buying an additional 528,976 shares during the period. Vanguard Group Inc. increased its holdings in Core Laboratories by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 3,079,882 shares of the oil and gas company's stock valued at $49,371,000 after buying an additional 32,492 shares during the period. State Street Corp increased its holdings in Core Laboratories by 3.3% during the fourth quarter. State Street Corp now owns 2,041,740 shares of the oil and gas company's stock valued at $32,729,000 after buying an additional 64,831 shares during the period. Dimensional Fund Advisors LP increased its holdings in Core Laboratories by 10.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,229,611 shares of the oil and gas company's stock valued at $19,711,000 after buying an additional 118,535 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Core Laboratories by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 1,114,935 shares of the oil and gas company's stock valued at $17,876,000 after buying an additional 8,497 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.